Abstract:Background: Introduction of the transcription factors Oct4, Sox2, Klf4, and c-Myc (OSKM) is able to 'reprogram' somatic cells to become induced pluripotent stem cells (iPSCs). Several microRNAs (miRNAs) are known to enhance reprogramming efficiency when co-expressed with the OSKM factors. The primate-specific chromosome 19 miRNA cluster (C19MC) is essential in primate reproduction, development, and differentiation. miR-524-5p, a C19MC member, is highly homologous to the reprogramming miR-520d-5p; we also reported that miR-524-5p was expressed in iPSCs but not mesenchymal stem cells (MSCs). This study aimed to elucidate possible contributions of miR-524-5p to the reprogramming process. Methods: A miR-524-5p precursor was introduced into human fibroblast HFF-1 in the presence of OSKM, and the relative number of embryonic stem cell (ESC)-like colonies that stained positively with alkaline phosphatase (AP) and Nanog were quantified to determine reprogramming efficiency. A miR-524-5p mimic was transfected to MSCs to investigate the effects of miR-524-5p on TP53INP1, ZEB2, and SMAD4 expression by real-time polymerase chain reaction (PCR) and Western blot. Direct gene targeting was confirmed by luciferase activity. A phylogenetic tree of TP53INP1 was constructed by the Clustal method. Contribution of miR-524-5p to cell proliferation and apoptosis was examined by cell counts, BrdU, MTT, and cell death assays, and pluripotency gene expression by real-time PCR. Results: Co-expressing the miR-524 precursor with OSKM resulted in a two-fold significant increase in the number of AP- and Nanog-positive ESC-like colonies, indicating a role for miR-524-5p in reprogramming. The putative target, TP53INP1, showed an inverse expression relationship with miR-524-5p; direct TP53INP1 targeting was confirmed in luciferase assays. miR-524-5p-induced TP53INP1 downregulation enhanced cell proliferation, suppressed apoptosis, and upregulated the expression of pluripotency genes, all of which are critical early events of the reprogramming process. Interestingly, the TP53INP1 gene may have co-evolved late with the primate-specific miR-524-5p. miR-524-5p also promoted mesenchymal-to-epithelial transition (MET), a required initial event of reprogramming, by directly targeting the epithelial-to-mesenchymal transition (EMT)-related genes, ZEB2 and SMAD4. Conclusions: Via targeting TP53INP1, ZEB2, and SMAD4, miR-524-5p contributes to the early stage of inducing pluripotency by promoting cell proliferation, inhibiting apoptosis, upregulating expression of pluripotency genes, and enhancing MET. Other C19MC miRNAs may have similar reprogramming functions.

MeCP2 Deficiency Promotes Cell Reprogramming by Stimulating IGF1/AKT/mTOR Signaling and Activating Ribosomal Protein-Mediated Cell Cycle Gene Translation.

Passive DNA Demethylation Preferentially Up-Regulates Pluripotency-Related Genes and Facilitates the Generation of Induced Pluripotent Stem Cells.

LMCD1 Facilitates the Induction of Pluripotency Via Cell Proliferation, Metabolism, and Epithelial‐mesenchymal Transition

c-Myc/microRNA-17-92 Axis Phase-Dependently Regulates PTEN and p21 Expression via ceRNA during Reprogramming to Mouse Pluripotent Stem Cells

microRNAs modulate iPS cell generation.

MeCP2, a Key Contributor to Neurological Disease, Activates and Represses Transcription

MeCP2: Multifaceted Roles in Gene Regulation and Neural Development

Synergetic Effects of DNA Methylation and Histone Modification During Mouse Induced Pluripotent Stem Cell Generation

Role of Mir-132/Methyl-cpg-binding Protein 2 in the Regulation of Neural Stem Cell Differentiation

Mettl14-driven senescence-associated secretory phenotype facilitates somatic cell reprogramming

Sin3a drives mesenchymal-to-epithelial transition through cooperating with Tet1 in somatic cell reprogramming

MeCP2 Facilitates Breast Cancer Growth Via Promoting Ubiquitination-Mediated P53 Degradation by Inhibiting RPL5/RPL11 Transcription

Coordination of Engineered Factors with TET1/2 Promotes Early-Stage Epigenetic Modification During Somatic Cell Reprogramming.

H3K9 Methylation is a Barrier During Somatic Cell Reprogramming into Ipscs.

KDM4B-mediated Reduction of H3K9me3 and H3K36me3 Levels Improves Somatic Cell Reprogramming into Pluripotency

Analysis of the interplay between MeCP2 and histone H1 during in vitro differentiation of human ReNCell neural progenitor cells

Correction To: MAP2K6 Remodels Chromatin and Facilitates Reprogramming by Activating Gatad2b-phosphorylation Dependent Heterochromatin Loosening

miR-524-5p of the primate-specific C19MC miRNA cluster targets TP53IPN1- and EMT-associated genes to regulate cellular reprogramming

Restricting Epigenetic Activity Promotes the Reprogramming of Transformed Cells to Pluripotency in a Line-Specific Manner

Analysis of the Epigenetic Signature of Cell Reprogramming by Computational DNA Methylation Profiles

Mir-6539 is a Novel Mediator of Somatic Cell Reprogramming That Represses the Translation of Dnmt3b